Zobrazeno 1 - 10
of 1 932
pro vyhledávání: '"A Nooka"'
Autor:
M Mohty, M Tomasson, B Arnulf, N Bahlis, M Prince, R Niesvizky, P Rodrgue-Otero, J Martine-Lopez, G Koehne, Y Jethava, A Gabayan, D Stevens, A Nooka, N Raje, S Iida, E Leip, U Conte, A Czibere, A Viqueira, V Blunk, A Lesokhin
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S404-S405 (2023)
Introduction/Objectives: To report the findings of extended follow-up and biweekly administration of elranatamab monotherapy in patients (pts) with relapsed/refractory multiple myeloma (RRMM) naïve to BCMA-directed therapies enrolled in Cohort A of
Externí odkaz:
https://doaj.org/article/14a84668d41c46b2b3aa4967551dcab6
Autor:
A Nooka, A Lesokhin, M Mohty, R Niesvizky, C Maisel, B Arnulf, S Larson, A Varshavsky-Yanovsky, X Leleu, L Karlin, D Vesole, N Bahlis, CF Larrea, N Raje, E Leip, U Conte, M Elmeliegy, A Viqueira, V Blunk, S Manier
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S405- (2023)
Introduction/Objectives: To evaluate the efficacy and safety of elranatamab in a pooled analysis of patients (pts) enrolled in MagnetisMM trials with relapsed or refractory multiple myeloma (RRMM) who had prior exposure to B-cell maturation antigen (
Externí odkaz:
https://doaj.org/article/8ebb8a99be494c20a60ee0ecd2fd2319
Autor:
N Raje, X Leleu, A Lesokhin, M Mohty, A Nooka, E Leip, U Conte, A Viqueira, V Blunk, S Manier
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S406-S407 (2023)
Introduction/Objectives: Multiple myeloma is a disease of elderly and frail people, who are often predominantly ineligible for intensive therapies. The objective of this analysis is to report the efficacy and safety of elranatamab monotherapy by age
Externí odkaz:
https://doaj.org/article/f3ba5367d2e1440dba52ac8f73c09409
Autor:
R Popat, S Usmani, A Garfall, N van de Donk, H Nahi, J San-Miguel, A Oriol, A Nooka, T Martin, L Rosinol, A Chari, L Karlin, L Benboubker, M Mateos, N Bahlis, P Moreau, B Besemer, J Martínez-López, S Sidana, L Pei, D Trancucci, R Verona, S Girgis, Y Olyslager, M Jaffe, C Uhlar, T Stephenson, R Van Rampelbergh, A Banerjee, J Goldberg, R Kobos, A Krishnan
Publikováno v:
HemaSphere, Vol 6, Pp 14-14 (2022)
Externí odkaz:
https://doaj.org/article/eb1943ec9ec94f6ebd05f44a710565f5
Autor:
Alberto Moreno, Kelly Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo, Jeffrey M. Switchenko, Bushra Wali, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha S. Joseph, Sagar Lonial, Kavita M. Dhodapkar, Madhav V. Dhodapkar, Mehul S. Suthar
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-5 (2024)
Abstract Hematological malignancies are associated with an increased risk of complications during SARS-CoV-2 infections. Primary series or monovalent booster vaccines reduce disease severity, hospitalization, and death among multiple myeloma patients
Externí odkaz:
https://doaj.org/article/03ac8fe724b84259b0f5de8ccd5b8e0e
Autor:
Niels W. C. J. van de Donk, Nizar Bahlis, Luciano J. Costa, María-Victoria Mateos, Ajay K. Nooka, Aurore Perrot, Alfred L. Garfall, Pragya Thaman, Keqin Qi, Clarissa Uhlar, Katherine Chastain, Margaret Doyle, Saad Z. Usmani
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/2f7e0c19cc154aafa61738446039d1ff
Autor:
Nisha S. Joseph, Jonathan L. Kaufman, Vilas A. Gupta, Craig C. Hofmeister, Madhav V. Dhodapkar, Lawrence H. Boise, Sara M. DiCamillo, Danielle Roberts, Ajay K. Nooka, Sagar Lonial
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Lenalidomide, bortezomib, and dexamethasone (RVd) have previously been established as standard-of-care induction therapy for newly diagnosed multiple myeloma (NDMM). More recently, randomized phase 3 data have demonstrated the benefit of the
Externí odkaz:
https://doaj.org/article/1432d47c2a254b14a2b8cb6d5ae2f228
Autor:
Manisha Bhutani, Brandon J. Blue, Craig Cole, Ashraf Z. Badros, Saad Z. Usmani, Ajay K. Nooka, Leon Bernal-Mizrachi, Joseph Mikhael
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract There are significant disparities with regards to incidence, timely diagnosis, access to treatment, clinical trial participation and health care utilization that negatively impact outcomes for African American patients with multiple myeloma.
Externí odkaz:
https://doaj.org/article/d6c25627337a4a6497077d63ec84eae7
Autor:
Cervantes-Pérez, Sergio Alan, Zogli, Prince, Amini, Sahand, Thibivilliers, Sandra, Tennant, Sutton, Hossain, Md Sabbir, Xu, Hengping, Meyer, Ian, Nooka, Akash, Ma, Pengchong, Yao, Qiuming, Naldrett, Michael J., Farmer, Andrew, Martin, Olivier, Bhattacharya, Samik, Kläver, Jasper, Libault, Marc
Publikováno v:
In Plant Communications 12 August 2024 5(8)
Autor:
Lin, Yi *, Qiu, Lugui, Usmani, Saad, Joo, Chng Wee, Costa, Luciano, Derman, Benjamin, Du, Juan, Einsele, Hermann, Fernandez de Larrea, Carlos, Hajek, Roman, Ho, P Joy, Kastritis, Efstathios, Martinez-Lopez, Joaquin, Mateos, Maria-Victoria, Mikhael, Joseph, Moreau, Philippe, Nagarajan, Chandramouli, Nooka, Ajay, O'Dwyer, Michael, Schjesvold, Fredrik, Sidana, Surbhi, van de Donk, Niels WCJ, Weisel, Katja, Zweegman, Sonja, Raje, Noopur, Otero, Paula Rodriguez, Anderson, Larry D, Jr, Kumar, Shaji, Martin, Tom
Publikováno v:
In The Lancet Oncology August 2024 25(8):e374-e387